• Explore /
  • Poster
  • / Phase 3 randomized, placebo-controlled trial of carboplatin (C) and paclitaxel (P) with/without veliparib (ABT-888) in HER2‒<i>BRCA</i>-associated locally advanced or metastatic breast cancer (BC).

Phase 3 randomized, placebo-controlled trial of carboplatin (C) and paclitaxel (P) with/without veliparib (ABT-888) in HER2‒BRCA-associated locally advanced or metastatic breast cancer (BC).

Abstract Poster

Authors

null

Shannon Puhalla

Magee-Womens Hospital of UPMC, Pittsburgh, PA

Shannon Puhalla , Hyo S. Han , Véronique Diéras , Michael Friedlander , George Somlo , Banu Arun , Hans Wildiers , Bella Kaufman , Jean-Pierre M. Ayoub , Melissa Shan , David Burmedi , Qin Qin , Jane Qian , Vincent L. Giranda , Stacie Peacock Shepherd

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

NCT02163694

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS1102)

DOI

10.1200/jco.2015.33.15_suppl.tps1102

Abstract #

TPS1102

Poster Bd #

215a

Abstract Disclosures

Similar Posters

First Author: Shannon Leigh Huggins-Puhalla

First Author: Shannon L Puhalla

First Author: Hyo S. Han

First Author: Joyce O'Shaughnessy